Jyoti (504076)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trailing P/E of 6.36 is optically inexpensive if current earnings can be sustained.
• Latest quarter is profitable: ₹53 Cr sales with ₹3 Cr net profit, showing some operating lift.
• ROCE is positive at 9.42%, meaning existing capital employed can generate a return.
• Sales growth of 2.35%, though modest, is at least positive.

Concerns

• ROE is -36.29%, and book value/debt-equity are N/A, implying a deeply impaired or unreliable equity base.
• Profit growth is -36.73% and Piotroski F-Score is 4/9, pointing to weak fundamental momentum and balance-sheet stress.
• Dividend yield is 0.00%, so shareholders receive no cash while waiting for recovery.
• PEG of 2.71 suggests the current price is not supported by the tiny sales growth rate.

AI Analysis

Let me look at Jyoti with a clear head. A P/E of 6.36 at ₹81.63 looks cheap, but I have learned that a low multiple can hide a bad business. Sales growth is just 2.35%, profit growth is minus 36.73%, and the company pays no dividend. The Piotroski F-Score of 4 out of 9 tells me the financial health is fragile. The most disturbing number is ROE of -36.29%. With no book value available and debt/equity not disclosed, I cannot trust the balance-sheet cushion that matters so much. How can I value a heavy electrical equipment maker whose equity is impaired? The latest quarter does show a net profit of ₹3 Cr on ₹53 Cr of sales, which is a 5.7% margin. But one quarter is not a trend. ROCE of 9.42% is at least positive, but it is not the kind of durable return on capital that creates owner earnings. This looks like a cyclical business with no real moat, in a competitive capital-heavy sector, facing an uncertain order environment. A PEG of 2.71, based on sales growth of 2.35%, tells me the current valuation is not cheap once growth is considered. The market has ranged from ₹48.50 to ₹112.45, so there is volatility and speculation. I need evidence of sustained demand, better margins, and a repaired balance sheet before I can call it an investment. At best, this is a possible special situation for a patient operator, not a Buffett-style sit-with-you-forever business.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer